RTSN.O (RTSN.O) News
Follow RTSN.O (RTSN.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Retension Pharma director Franklin M. Berger acquires 10,000 common shares for $120,000
Retension Pharmaceuticals director Franklin M. Berger increased exposure to the stock via conversion into 12,517 common shares. Separate purchase added 10,000 common shares at $12, held indirectly through FMB Research. D
REGULATION | Oct 13, 2026, 10:11 PM UTC
L
Retension Pharmaceuticals adopts amended and restated bylaws ahead of IPO close
Retension Pharmaceuticals adopted amended and restated bylaws that took effect immediately before its IPO closing on Oct. 13, 2026. The updated bylaws had been authorized by the board and stockholders ahead of the offeri
REGULATION | Oct 13, 2026, 08:11 PM UTC